Lucid Diagnostics Inc. LUCD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.60% | 24.89% | 23.03% | 8.28% | 5.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.60% | 24.89% | 23.03% | 8.28% | 5.01% |
| Cost of Revenue | -8.94% | -4.55% | -3.56% | -6.03% | 8.48% |
| Gross Profit | 64.92% | 54.24% | 42.89% | 28.62% | -15.02% |
| SG&A Expenses | 12.53% | 11.64% | 8.28% | 13.54% | 12.42% |
| Depreciation & Amortization | -0.24% | -0.24% | -0.24% | -10.83% | -57.65% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.08% | 7.32% | 4.78% | 7.83% | 6.25% |
| Operating Income | -6.66% | -5.73% | -3.18% | -7.79% | -6.37% |
| Income Before Tax | 8.91% | 5.43% | 27.20% | -27.41% | -18.89% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.91% | 5.43% | 27.20% | -27.41% | -18.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.91% | 5.43% | 27.20% | -27.41% | -18.89% |
| EBIT | -6.66% | -5.73% | -3.18% | -7.79% | -6.37% |
| EBITDA | -6.80% | -5.84% | -3.27% | -8.65% | -8.18% |
| EPS Basic | 54.53% | 55.18% | 60.81% | 23.35% | 20.76% |
| Normalized Basic EPS | 46.95% | 49.84% | 51.45% | 44.16% | 35.77% |
| EPS Diluted | 54.53% | 55.18% | 60.81% | 23.35% | 20.76% |
| Normalized Diluted EPS | 46.95% | 49.84% | 51.45% | 44.16% | 35.77% |
| Average Basic Shares Outstanding | 93.08% | 103.51% | 112.02% | 101.68% | 79.82% |
| Average Diluted Shares Outstanding | 93.08% | 103.51% | 112.02% | 101.68% | 79.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |